2
Orphan Designations
0
FDA Approvals
2
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| childhood acute myeloid leukemia | luveltamab tazevibulin | Orphan Designation | - |
| plasma cell myeloma | antibody-drug conjugate comprised of a human aglycosylated anti-CD74 IgG1 antibody (SP7219) and two non-cleavable maytansinoid linker warheads | Orphan Designation | - |